LFB_Group

LFB is a pharmaceutical group specialized in biopharmaceuticals.

[LFB_Group @LFB_Group]

🎉 LFB and all its employees wish you all the best for 2025, a year full of professional accomplishments and success! 🎊 Happy new year!

[LFB_Group @LFB_Group]

🇪🇺@LFB_Group strengthens its plasma collection network in Europe thanks to the acquisition of Amber Plasma.
With the increasing needs of patients, LFB secures the supply of plasma for its biomedicines for the treatment of serious and often rare diseases.
https://t.co/RojmGcQvhw

[LFB_Group @LFB_Group]

@LFB_Group presents its Raison d’être:
👉✅LFB, expertise committed to life✅
📑More information here : https://t.co/wPirnxfyVj
📽️Discover the video : https://t.co/5VzGhxMYRJ

[LFB_Group @LFB_Group]

Join us at #NATA2024 on the @LFB_Group booth#17 and for our symposium “How to effectively manage coagulation disorders in the obstetric setting” on April 18th from 15:00-16:00 CET.
✅See details here: https://t.co/3RWkXhZH47
#NATA #PPH #LFB #obstetrichaemorrhage #pbm

[LFB_Group @LFB_Group]

✅17/04 World Hemophilia Day. @LFB_Group employees pursue their commitment to supporting people living with any bleeding disorders.🩸
💪LFB works day in, day out to guarantee “Equitable access for all: recognizing all bleeding disorders.”
#WorldHemophiliaDay #WHD2024

[LFB_Group @LFB_Group]

➡ Join us at the @NATAforum congress in 📍 Bologna Italy to attend our symposium ✅ How to effectively manage coagulation disorders in the obstetric setting❔✅ on 🗓 Thursday 18th April 2024 from 15.00 to 16.00 CET.

[LFB_Group @LFB_Group]

✅LFB BIOMANUFACTURING and @SartoriusGlobal
collaborate on cell line development and manufacturing
https://t.co/csDdUGCyBI

[LFB_Group @LFB_Group]

💚Today, 29 February 2024, is Rare Disease Day. Discover Céline's message below 👇
#rarediseaseday

[LFB_Group @LFB_Group]

Please join @LFB_Group sponsored symposium at @EAHADnews on 🗓 7th February 2024, 14:00 -15:15 CET. 👨‍⚕️ Our distinguished panel of experts, Prof. Cedric HERMANS, Prof. Castaman and Dr Benson will address key challenges in #Haemophilia with inhibitors and Von Willebrand Disease.

[LFB_Group @LFB_Group]

🚀At the end of 2024, for its 30th anniversary, @LFB_Group will be opening its new production facility in Arras: immerse yourself into the heart of this #bioproduction site.
📽️👇https://t.co/cMwfSgQLPj

[LFB_Group @LFB_Group]

🎆@LFB_Group and all employees wish you all the best for 2024, a year full of professional projects and success! Happy new year 🎉!

[LFB_Group @LFB_Group]

📣 @Groupe_LFB plans to double bioproduction capacity at its Alès site with the support of “France 2030”.
@SGPI_avenir @Bpifrance #france2030 #CDMO #bioproduction
▶️Read the press release: https://t.co/bVDvPoEagJ

[LFB_Group @LFB_Group]

📢The @LFB_Group corporate new brochure is available.
👉To read the PDF : https://t.co/ozKaf2tO3V
👇📽️And discover the 2023 edition in video : https://t.co/jWyRCOP4mO

[LFB_Group @LFB_Group]

📣 📽️Discover the video interview with Jacques Brom, CEO of @LFB_Group, who communicates on the company’s objectives and its mission which inspires all LFB employees: the commitment to serve #patients.
👇Watch Jacques Brom video👇https://t.co/07McflGYrn

[LFB_Group @LFB_Group]

🤝@LFB_Group is pleased to share the press release from the @AcadPharm, the French Academy of Pharmacy regarding the call for significantly boosting the plasma collection efforts to secure the production and meet patients’ needs of plasma-derived medicines.

[Academie Nationale de Pharmacie @AcadPharm]

[#alerte📣] "Doubler la collecte du plasma pour fractionnement en France : une urgence de santé publique pour renforcer la souveraineté sanitaire et sécuriser la mise à disposition des médicaments dérivés du plasma". https://t.co/AfpdbF7rZs @LFB @EFS #medicament #plasma

[LFB_Group @LFB_Group]

📣11/06 is the world Dysimmune and Inflammatory #Neuropathies Day. The opportunity to recall that efforts still need to be made to improve diagnosis and management of patients suffering from these rare diseases. @LFB_Group takes part in this Day. https://t.co/7dF4owmuDR

[LFB_Group @LFB_Group]

📣Don’t miss the @LFB_Group interactive live webinar, in German language, on 🗓 06/13, from 6.00 to 7.30 pm, on the interdisciplinary approach on von Willebrand syndrome, with a focus on elderly 🚺 female #patients. German program in video here: https://t.co/lUDX8ebPnM & in UK👇

[LFB_Group @LFB_Group]

Any wound, shock or surgery will activate a process which allows us to heal: the coagulation cascade.
On the occasion of the World Hemophilia Day, discover or rediscover the video “What is the coagulation cascade?” #WHD2023

[LFB_Group @LFB_Group]

📢 📽 Last episode of @LFB_Group series #ThePowersOfBlood. Focus today on the coagulation cascade, a chain reaction of activated coagulation factors to stop bleeding.
Watch the entire series here 👉👉https://t.co/pfXQstl57F

[LFB_Group @LFB_Group]

On this World Hemophilia Day, LFB is continuing its commitment to shedding light on this rare disease and maintaining access to treatment for as many patients as possible.
#WHD2023 #hemophilia

[LFB_Group @LFB_Group]

📢 [Reminder!]
Applications for the "LFB Research Grant in Immunology 2023" announced last February are still open.
Find all the detailed information about these 2 awards, eligibility criteria and application forms, by following the link: https://t.co/TYPMXX4QWv

[LFB_Group @LFB_Group]

@LFB_Group continues its commitment to patients treated with immunoglobulins, and launches the 3rd edition of its #LFB Research Grant in Immunology with two prizes totaling €30,000. All the information about this grant 👇
https://t.co/TYPMXX4QWv